Ming Zhao

6PUBLICATIONS
44CO-AUTHORS
Molecular targetsTumour immunologyApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Apr 29, 2025
Efficacy of ATR Kinase Inhibitor Elimusertib Monotherapy or Combination in Tumors with DNA Damage Response Pathway and Other Genomic Alterations.

Kaushik Varadarajan, Christian X Cruz Pico, Kurt W Evans

|Nov 25, 2024
Antitumor Activity and Biomarker Analysis for TROP2 Antibody-Drug Conjugate Datopotamab Deruxtecan in Patient-Derived Breast Cancer Xenograft Models.

Funda Meric-Bernstam, Erkan Yuca, Kurt W Evans

|Nov 08, 2024
Utilizing Patient-Derived Xenografts to Model Precision Oncology for Biliary Tract Cancer.

Timothy P DiPeri, Kurt W Evans, Stephen Scott

|Feb 15, 2024
Co-clinical Trial of Novel Bispecific Anti-HER2 Antibody Zanidatamab in Patient-Derived Xenografts.

Timothy P DiPeri, Kurt W Evans, Bailiang Wang

|Aug 11, 2023
Epigenetically upregulating TROP2 and SLFN11 enhances therapeutic efficacy of TROP2 antibody drug conjugate sacitizumab govitecan.

Ming Zhao, Timothy P DiPeri, Maria Gabriela Raso

|Jun 06, 2023
Adavosertib Enhances Antitumor Activity of Trastuzumab Deruxtecan in HER2-Expressing Cancers.

Timothy P DiPeri, Kurt W Evans, Maria Gabriela Raso

Pageof 1

Frequent Collaborators

6 joint publications

Maria Gabriela Raso

6 joint publications

Funda Meric-Bernstam

5 joint publications

Kurt W Evans

5 joint publications

Yasmeen Rizvi